Commercial Access Only
Specimen SS-COM-BTR-0917 // BITTER
Clear Brassica T1-IV-PH
Brassica oleracea var. sabellica
Kale
Clear Brassica SeriesTier 1
Target Trait
65
% reduction
Reported target: 65% bitter reduction
Technical Specifications
Genomic Edits
10
GC Content
(52%)
Construct Length
5,700 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Pathway Edits
- TAS2R38 partial suppression
- Glucosinolate pathway attenuation
Key Interventions
TAS2R38 RNAi knockdown constructSinigrin reduction via glucosinolate pathway attenuation
Application Domains
PharmaceuticalResearch
Intended Use
Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.